On Wednesday, the FDA approved the new round of COVID-19 vaccines from Pfizer, Moderna, and Novavax for use by seniors over the age of 65. But for anyone younger than that, the FDA approval only mentions people who have “at least one underlying condition that puts them at high risk for severe outcomes from COVID-19.” […]
Original: https://www.theverge.com/news/767208/fda-covid-vaccine-approval-rfk-cdc-director-susan-monarez